The library will be closed between August 10, 2026 and August 16, 2026. During this period, it will be possible to upload publications, but all other services will be suspended.
Héja, M.,
Oláh, L.:
Efficacy of anti-calcitonin gene-related peptide monoclonal antibodies in hemiplegic migraine: a case report and review of literature.
Front. Neurol. 16, 1-7, 2025.
Q3
Pharmacology, Toxicology and Pharmaceutics (miscellaneous)
3.
Nguyen, N.,
Ho Quang Tri, V.,
Nguyen Ngoc Dan, V.,
Bao Tran, N.,
Oláh, L.,
Héja, M.:
Safety, efficacy, and compliance of moderate-to-high dose eptinezumab and erenumab in chronic migraine patients with medication-overuse headache: an updated systematic review and meta-analysis.
J Headache Pain. 26 (1), 1-11, (article identifier: 99), 2025.
Héja, M.,
Fekete, I.,
Márton, S.,
Horváth, L.,
Fekete, K.:
Impact of COVID-19 pandemic on acute stroke care in a tertiary stroke centre.
Sci. Rep. 14 (1), 1-17, (article identifier: 31408), 2024.
Fekete, K.,
Héja, M.,
Márton, S.,
Tóth, J.,
Horváth, L.,
Harman, A.,
Fekete, I.:
Predictors and long-term outcome of intracranial hemorrhage after thrombolytic therapy for acute ischemic stroke: A prospective single center study.
Front. Neurol. 14, 1-11, (article identifier: 1080046), 2023.
Héja, M.,
Fekete, I.,
Horváth, L.,
Márton, S.,
Fekete, K.:
Experiences With Intravenous Thrombolysis in Acute Ischemic Stroke by Elderly Patients?: a "Real World Scenario".
Front. Neurol. 12, 1-10, (article identifier: 721337), 2021.
